Tevogen.AI Secures International Patent, Enhancing Vaccine Development Potential

Warren, Friday, 18 July 2025.
Tevogen Bio Holdings Inc. achieves a major breakthrough with its AI technology patent for predicting immunologically active peptides, promising advancements in vaccine development and biomedicine.